oxybutynin chloride
NDC 62135-507, OXYBUTYNIN CHLORIDE, tablet, extended release, from Chartwell RX, LLC.
- Product NDC
- 62135-507
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078503
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-507 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-507-90 | 62135050790 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-507-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e464c8dd-5222-4a6b-b7e9-ca608a403c6eNADAC price for package 62135050790
GET /v1/drugs/nadac/62135050790
Use it
Look up 62135-507 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-507 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-507. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.